E mbryonic stem cells (ESCs) are an excellent model for studying the generation of the three main germ layers, endoderm, mesoderm and ectoderm 1 . The first event during the transition of ESCs into more differentiated cells is the exit from pluripotency, which includes silencing of the core pluripotency transcription factors Oct4, Sox2 and Nanog [2][3] [4] . This process can be externally initiated either by deprivation of self-renewal signals 5 or by exposure of the cells to differentiation-inducing cues 6 . Subsequently, germ layer-instructive transcription factors become upregulated and activate markers that define the various lineages 4 . These factors comprise Brachyury (T) and Gata4 for mesoderm, Gata6, Gata4 and Foxa2 for endoderm, and Pax6 and Sox1 for neuroectoderm 3, 4, 6, 7 . Screens with ESC reporter lines and haploid ESCs have identified several regulators required for pluripotency exit, including several transcription factors and RNA-binding proteins, all of which were shown to affect members of the pluripotency network [8] [9] [10] [11] [12] [13] . Besides transcription factors and non-coding RNAs, chromatinrelated factors (CRFs) play an important role in ESC differentiation, which involves a progressive transition from a relatively open chromatin state to a more compact one Here, we report that Whsc1 is required for efficient pluripotency exit and mesendoderm specification, independent of its methyltransferase activity. These effects can be explained by its ability to activate several mesendoderm regulators.
. Besides transcription factors and non-coding RNAs, chromatinrelated factors (CRFs) play an important role in ESC differentiation, which involves a progressive transition from a relatively open chromatin state to a more compact one 14 . Several CRFs are broadly involved in ESC differentiation, such as Polycomb group proteins that are required for the repression of pluripotency-associated and lineage-inappropriate genes 15 . Others act in a more restricted fashion, as exemplified by the requirement of Setd2 for endodermal differentiation 16 , Mel18 for mesodermal differentiation 17 and Zrf1 for neuroectodermal differentiation 18 . Here, we report that Whsc1 is required for efficient pluripotency exit and mesendoderm specification, independent of its methyltransferase activity. These effects can be explained by its ability to activate several mesendoderm regulators.
Results
Whsc1 is required for efficient exit from pluripotency. To search for CRFs that play a role in pluripotency exit and subsequent ESC differentiation, we performed an in silico screen by analysing datasets that record transcriptome changes during the differentiation of mouse ESCs into embryoid bodies (EBs). We compiled a list of 653 genes encoding histone writers and readers, histone variants, nucleosome positioning proteins and a selection of long non-coding RNAs (Supplementary Table 1 and Supplementary Fig. 1a ). Three candidates consistently scored among the most upregulated genes. These were Cbx4 (encoding a Polycomb group protein that has been shown to orchestrate ESC differentiation 19 ), L3mbtl3 (a putative Polycomb group family member 20 ) and Whsc1 (encoding a SET-domain methyltransferase, which in humans is associated with Wolf-Hirschhorn syndrome 21 ). To study whether these candidates are required for pluripotency exit, we tested the effects of knockdowns on the differentiation of a pluripotency reporter ESC line. This line, which contains a destabilized version of green fluorescent protein (GFP) knocked into the Rex1 locus (Rex1GFPd2) 8 , was induced to differentiate by transfer into medium containing N2 and B27 supplements, activin A and foetal bovine serum (FBS) 22, 23 . On induction, the reporter line became GFP negative within 48-72 h (Fig. 1a-c) , confirming that the loss of Rex1 expression is a highly sensitive readout for exit from the pluripotent state 24, 25 . Concomitantly, the cells downregulated pluripotency-associated genes and upregulated mesendoderm-and neuroectoderm-specific genes ( Supplementary Fig. 1b) .
Two independent small hairpin RNA (shRNA) lentiviral constructs were used to knock down the expression of each of the three candidate genes. After induction of differentiation, cells expressing scrambled shRNA (shScr) became GFP negative within 48-72 h postinduction, as did cells expressing shCbx4 and shL3mbtl3 ( Supplementary Fig. 1c ). In contrast, 25-35% of ESCs transduced with the shWhsc1 constructs retained GFP expression (Fig. 1b,c) . Notably, both Whsc1 knockdown constructs strongly reduced the expression of both Whsc1 messenger RNA (mRNA) and the ~180 and ~100 kDa protein isoforms (Fig. 1d) . Interestingly, shWhsc1 
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ESCs retained elevated expression levels of the pluripotency genes Rex1, Pou5f1, Nanog, Lin28a and Esrrb (Fig. 1e ). In addition, Whsc1-depleted cells, when re-plated after induced differentiation, yielded large numbers of colonies positive for alkaline phosphatase (an indicator of pluripotency), even after two consecutive rounds of treatment, whereas no such colonies could be recovered from control cells as early as after one round ( Supplementary Fig. 1d ). Depletion of Whsc1 in ESCs resulted in neither an upregulation of pluripotency factors nor an alteration of the cells' growth kinetics ( Supplementary Fig. 1e-g ), ruling out more indirect effects on pluripotency exit.
In summary, Whsc1 depletion impaired the downregulation of pluripotency markers, indicating a requirement for efficient pluripotency exit.
Depletion of Whsc1 impairs induction of mesendoderm differentiation in vitro and in vivo.
To evaluate the effect of Whsc1 depletion on the differentiation capacity of ESCs, we examined EBs derived from knockdown ESCs (Fig. 2a) . Whsc1-depleted EBs were smaller than those from control ESCs (Fig. 2b) , and exhibited lower levels of Whsc1 mRNA and protein while retaining pluripotency factor expression (Fig. 2c,d ). Importantly, Whsc1-depleted EBs also showed strongly reduced expression of the mesendoderm regulator genes Gata4, T, Gata6, Foxa2, Sox17 and Flk1, while neuroectodermal gene expression (Sox1, Pax6 and Nes) remained unaffected (Fig. 2c) . In addition, when shWhsc1 EBs were dissociated and re-plated onto mouse embryo fibroblasts in medium with 2i and leukaemia inhibitory factor (LIF), they formed large numbers of alkaline phosphatase-positive colonies, whereas control cells yielded few such colonies (Fig. 2e) , suggesting that shWhsc1 EBs retained pluripotent cells. Moreover, EBs derived from shWhsc1 epiblast stem cells (EpiSCs) also retained Pou5f1 expression and showed reduced developmental potential towards the mesendoderm lineage ( Supplementary Fig. 2a ).
To probe their differentiation potential in vivo, we generated teratomas in immunodeficient mice. Control cell-derived teratomas contained tissues from all three germ layers, including muscle, cartilage, gut epithelium and neuro-epithelium. In contrast, derived Whsc1-depleted teratomas were mainly composed of neuro-epithelium and poorly differentiated cells (Supplementary Fig. 2b ). Accordingly, shWhsc1 teratomas retained pluripotency and neuroectoderm marker expression while showing reduced levels of mesendoderm markers ( Supplementary Fig. 2c ).
Since both EBs and teratomas comprise a complex mixture of cells, we next tested the effects of Whsc1 knockdown on the directed differentiation of ESCs towards mesoderm, endoderm and ectoderm. Whsc1-depleted cells generated significantly fewer beating cardiomyocyte-containing colonies than control cells (Supplementary Fig. 3a and Supplementary Videos 1 and 2) and a reduced expression of the cardiac regulators Mef2c and Nkx2.5 at 10 d postinduction, while exhibiting increased Rex1 and Pou5f1 expression ( Supplementary Fig. 3b,c) . To test the effects of shWhsc1 on definitive endoderm differentiation, Eomes-GFP reporter ESCs 26 (Eomes being a mesendodermal marker) were transferred into medium containing activin A, Fgf4, heparin, PI-103 and CHIR 27 . Seven days later, about 30% of control cells became GFP positive, whereas only 5% of Whsc1-depleted cells did so ( Supplementary  Fig. 3d,e) . In line with these findings, shWhsc1-expressing cells showed impaired upregulation of the endoderm markers Cxcr4, Cldn6, Foxa2, Gata6 and Sox17, and inefficient downregulation of Supplementary Fig. 8 . e, Expression of pluripotency genes 72 h after induction of exit from pluripotency. In b-e, n = 3 independent experiments were performed with similar results. Data in d (left) and e represent means ± s.d. and P values were calculated by two-tailed unpaired t-test.
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NaTurE CEll BiOlOgy the pluripotency regulators Rex1, Pou5f1 and Esrrb ( Supplementary  Fig. 3f,g ). Finally, we derived neural progenitor cells 28 from control and Whsc1 knockdown ESCs and found no significant differences in the expression of the neural markers Pax6, Sox1 and Nes, nor that of Pou5f1 and Esrrb (Supplementary Fig. 3h ).
Taken together, the results obtained with EBs, teratomas and directed germ layer induction experiments confirm that the delay of pluripotency exit induced by Whsc1 depletion is coupled to an impairment of mesendoderm differentiation.
The catalytic SET domain of Whsc1 is dispensable for efficient pluripotency exit and mesendoderm differentiation. Whsc1 requires the catalytic SET domain on the carboxy (C) terminus to di-methylate the lysine 36 on histone 3 ( Supplementary Fig. 4a ) 29, 30 . This function has been linked to the normal foetal heart and cartilage development in a murine model in which the SET domain of Whsc1 was excised 31 . Surprisingly, however, ESCs derived from these mice (hereafter referred to as ΔSET) behaved like wild-type ESCs in our assays ( Supplementary Fig. 4b,c) . In contrast, the expression of shWhsc1.4, which targets the 5′ end of Whsc1 mRNA in ΔSET ESCs, caused a delay in pluripotency exit, and EBs derived from these cells also showed retention of pluripotency gene expression and selective reduction of mesendoderm marker expression ( Supplementary Fig. 4b,c) . As the Whsc1 gene produces two major transcripts encoding a full-length protein of ~180 kD and a short isoform of ~100 kD that corresponds to the amino (N)-terminal , respectively. The P value was calculated by two-tailed Mann-Whitney U-test. Scale bar: 500 μm. c, Expression of Whsc1, pluripotency, mesendoderm and ectoderm markers in day 6 EBs quantified by RT-qPCR from control and Whsc1-depleted Rex1GFPd2 cells. d, Levels of Whsc1 and pluripotency factors in day 6 EBs evaluated by western blot from control and Whsc1-depleted Rex1GFPd2 cells. Tubulin was used as a loading control. n = 2 independent experiments were performed with similar results. Scanned images of unprocessed blots are shown in Supplementary  Fig. 8 . e, Schematic of the EB re-plating assay (top) and images of alkaline phosphatase-stained colonies obtained from control and Whsc1-depleted EBs (bottom). Scale bars: 1 mm. Right, quantification of alkaline phosphatase-positive colonies. In c and e, data represent means ± s.d. from n = 3 independent experiments, and P values were calculated by two-tailed unpaired t-test.
NaTurE CEll BiOlOgy portion (Fig. 3a) , we examined Whsc1 expression by western blot. We found that ΔSET ESCs also express two proteins: the larger protein corresponds to a C-terminal truncated form of ~130 kD and the 100 kD isoform ( Supplementary Fig. 4d ). These results raise the possibility that, in the absence of the catalytic SET domain, the N terminus of Whsc1 plays a role in both the induction of pluripotency exit and mesendoderm specification.
To explore this hypothesis, we used a clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) approach to generate an ESC line with a complete Whsc1 knockout, by targeting exon 1 and exon 15. This led to the deletion of a fragment of ~40 kilobases (kb) encoding both the long and short isoforms of Whsc1 (Fig. 3a) , and also eliminated multiple AUGs that could serve as potential start codons. Whsc1 knockout (Whsc1 −/− ) ESCs lacked both protein isoforms (Fig. 3b) , expressed unaltered levels of Sox2, Oct4 and Nanog (Fig. 3b) , and showed delayed downregulation of Rex1, Pou5f1 and Nanog after differentiation induction (Fig.  3c) . EB derivatives were impaired in the upregulation of mesendoderm genes, but not of neuroectoderm genes, and exhibited delayed downregulation of Rex1, Pou5f1 and Nanog (Fig. 3d) .
To test the possibility that the observed phenotype of Whsc1 [8] [9] [10] [11] [12] [13] 32 ) (Supplementary Table 2 ). In summary, our data show that the SET domain is dispensable for the ability of Whsc1 to facilitate rapid pluripotency exit and to induce mesendoderm specification.
The N-terminus of Whsc1 is sufficient to induce pluripotency exit and mesendoderm differentiation. In an attempt to show that the N-terminal domain of Whsc1 is sufficient for the biological properties of the protein in ESC differentiation, we performed rescue experiments. For this, we engineered Flag-tagged constructs of full-length human WHSC1 (FL-WHSC1), two N-terminal fragments of different lengths (Nter-1 and -2) and a C-terminal portion containing the SET domain (Fig. 4a) . Whsc1 −/− cells expressing these constructs were subjected to the pluripotency exit and germ layer formation assays; as expected, FL-WHSC1 rescued the cell's phenotype in both assays (Fig. 4b,c) . Remarkably, the expression of either N-terminal construct (Nter-1 or -2) in Whsc1 −/− cells was sufficient to rescue the cells' phenotype, showing rapid downregulation of Rex1, Pou5f1 and Nanog after induction of differentiation. In contrast, the C-terminal construct containing the SET domain failed to rescue (Fig. 4b) . In line with these findings, the expression of either N-terminal construct was also sufficient to restore mesendoderm marker upregulation and pluripotency gene downregulation during EB formation, while the C-terminal construct showed no such effect (Fig. 4c) . Since Whsc1 has been described to methylate H3K36 and to alter EZH2 binding in multiple myeloma cells 29, 30 , we compared Whsc1 +/+ and Whsc1 −/− ESCs for the relevant histone marks. However, we found no significant differences in the global levels of H3K36me2, H3K36me3 and the EZH2-associated H3K27me3 mark ( Supplementary Fig. 4e ).
Our findings show that the N terminus of Whsc1 is sufficient to facilitate rapid exit from pluripotency and induce mesendoderm formation. They also suggest that the methyltransferase activity of Whsc1 acts in a cell context-dependent manner.
Whsc1 mediates enhancer activation of mesendoderm regulators. Our observations raise the possibility that Whsc1 directly controls the expression of transcription factors that specify mesodermal and endodermal lineages. We therefore asked whether Whsc1 binds to and activates mesendodermal-specific enhancers. We focused on genomic loci of the mesendoderm instructive transcription factor genes Gata4, T, Gata6 and Foxa2. Putative enhancers of the neuroectodermal transcription factor genes Pax6 and Sox1 were included as controls. To identify candidate regulatory regions of these genes, we mapped the distribution of the enhancer mark H3K27ac in cells positive for either of the mesendodermal markers Eomes or Flk1, in mesendodermal progenitors induced by activin A, and in neural progenitor cells. In addition, as it has been shown that promoterenhancer interactions occur mainly within the same topologically associating domains (TADs) 33, 34 , we focused on regions within the same TAD. These analyses revealed the presence of several putative enhancers selectively marked by H3K27ac in either mesendodermal or neuroectodermal cells ( Fig. 5a and Supplementary Fig. 5a ). To explore whether Whsc1 binds to these regions, we performed chromatin immunoprecipitation (ChIP) analyses using day 6 EBs. This showed that Whsc1 is significantly enriched at 8 out of 26 putative enhancers tested within the T, Gata6, Foxa2 and Gata4 loci and that this enrichment is reduced in Whsc1 −/− EBs ( Fig. 5b and Supplementary Fig. 5b ). Notably, no significant Whsc1 binding was observed in 12 regions specifically marked by H3K27ac in the Pax6 and Sox1 loci in ectodermal cells ( Supplementary Fig. 5b ). To further explore whether these Whsc1-bound regulatory regions are required for target gene regulation, we performed UMI-4C experiments using promoter regions of T, Gata6, Foxa2 and Gata4 as viewpoints in ESCs and day 6 EBs, comparing Whsc1 +/+ and Whsc1 −/− cells. We found that most Whsc1-bound putative mesendodermal enhancers appear to interact with target gene promoter regions in Whsc1 +/+ day 6 EBs but not in ESCs, and that these contacts are lost/decreased in Whsc1 −/− day 6 EBs ( Fig. 5c and Supplementary Fig. 5c ). These observations are consistent with the notion that the relevant regions are involved in Whsc1-mediated target gene regulation.
To test whether Whsc1 binding is associated with enhancer activity, we monitored H3K27ac enrichment at Whsc1-bound regions in Whsc1 +/+ and Whsc1 −/− day 6 EBs within the T, Gata6, Foxa2 and Gata4 loci. Regions not bound by Whsc1 served as controls. All ten Whsc1-bound regions showed a significant decrease of H3K27ac decoration in the Whsc1 −/− cells. In contrast, in the same cells, 14 out of 16 regions not bound by Whsc1, and all 12 sites within the Sox1 and Pax6 regions tested, showed no significant H3K27ac change ( Fig. 5d and Supplementary Fig. 5d ). Similar results were obtained for the H3K4me2 mark ( Supplementary Fig. 5e ). In addition, the ten Whsc1-bound regions showed no significant binding of Whsc1 in ESCs (Supplementary Fig. 5f ) and their H3K27ac enrichment in ESCs was lower than in day 6 EBs (Supplementary Fig. 5f ).
Taken together, these data show that Whsc1 binding is associated with active enhancers of target genes.
Whsc1 interacts with Brd4 to facilitate activation of mesendoderm enhancers. The bromodomain protein Brd4 has been reported to be required for enhancer activation and gene expression 35 and to interact with Whsc1 (ref. 36 ). We therefore tested whether Brd4 interacts with Whsc1 at the enhancer regions described above ( Fig. 5b and Supplementary Fig. 5b ). We found that in day 6 Whsc1 +/+ EBs Brd4 indeed binds to the enhancers of T, Gata6, Foxa2 and Gata4, as well as to those of Sox1 and Pax6. Importantly, Brd4 binding was significantly decreased in Whsc1
EBs at the mesendoderm enhancers but not at the ectoderm enhancers (Fig. 6a ). In addition, EBs treated during their formation with the Brd4 inhibitor JQ1 (ref. 37 ) showed reduced expression of the mesendodermal regulator genes Gata4, T, Gata6 and Foxa2, compared with dimethyl sulfoxide-treated control EBs (Fig. 6b) . . b, Western blot of Whsc1 and the pluripotency factors Sox2, Oct4 and Nanog in Whsc1 +/+ and two Whsc1 −/− ESC clones. Tubulin was used as a loading control. n = 2 independent experiments were performed with similar results. Scanned images of unprocessed blots are shown in Supplementary Fig. 8 

NaTurE CEll BiOlOgy
We also observed an increase in the neuroectoderm markers Sox1, Pax6 and Nestin in JQ1-treated EBs, in line with the reported induction of neural differentiation after Brd4 depletion in ESCs 38 ( Fig. 6c) . Moreover, both Whsc1 isoforms were found to co-immunoprecipitate with Brd4 in day 6 EB extracts ( Fig. 6d) , consistent with the notion that the N-terminus of Whsc1 is sufficient for this interaction.
Together, our results show that Whsc1 interacts with Brd4, and that this interaction favours the activation of mesendoderm enhancers but not of ectoderm enhancers.
Gata6 recruits Whsc1 to a subset of mesendodermal enhancers. Next, we asked whether mesendoderm-specific regulators are also able to interact with Whsc1 and recruit the factor to their target sites. As a model, we chose to study Gata6; first, we performed coimmunoprecipitation experiments. Indeed, both long and short Whsc1 isoforms co-immunoprecipitate with Gata6 in day 6 EBs, suggesting that the SET domain, which is not contained in the 100-kDa isoform, is dispensable for this interaction (Fig. 6e) . To probe the second question, we generated Gata6 knockout ESCs by CRISPR-Cas9-mediated genome editing. These cells retain an 
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-/-plus C terminal P = 0.030101 P = 0.003219 P = 0.003227 P = 0.008556 P = 0.013852 P = 0.000314 P = 0.000373 P = 0.004498 P = 0.018387 +/+ and Whsc1 −/− ESCs and day 6 EBs. Top, average contact profiles generated from the average of n = 2 independent biological replicates. Bottom, average contact fold change of day 6 EBs versus day 0 ESCs from n = 2 independent biological replicates. d, H3K27ac enrichments on putative enhancers of T (left) and Gata6 (right) were quantified by ChIP-qPCR in day 6 Whsc1 +/+ and Whsc1 −/− EBs. In b and d, data represent means ± s.d. from n = 3 independent experiments, and P values were calculated by two-tailed unpaired t-test.
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−/− ESCs were then used to generate EBs and to perform Whsc1 ChIP experiments in day 4 EBs. We tested all ten previously identified Whsc1-bound enhancer regions of T, Gata4, Gata6 and Foxa2 and found significantly decreased binding of Whsc1 at six of these regions (Fig. 6f) .
These findings suggest that the mesendodermal lineage specifier Gata6 is capable of recruiting Whsc1 to a subset of mesendodermspecific enhancers. Supplementary Fig. 6a) . The cells were then induced to differentiate by transfer into N2B27 medium containing activin A and FBS. While control siRNA cells showed a complete loss of GFP expression at 48 h postinduction, a significant proportion of cells transfected with siRNAs against Gata6, T, Gata4 and Foxa2 remained GFP positive (Supplementary Fig. 6b ). To further study the role of these factors in pluripotency exit, we tested Gata6 and Foxa2 knockout ESCs generated by CRISPR-Cas9-mediated genome editing. Monitoring gene expression at different times after induction of differentiation revealed that, as for Whsc1 −/− cells, Gata6 −/− and Foxa2 −/− cells showed a delayed downregulation of the pluripotency genes Oct4, Rex1 and Nanog (Fig. 7a) . The retention of Oct4 and Nanog expression in Gata6 and Foxa2 knockout cells was also confirmed at the protein level in cells induced to differentiate for 72 h (Fig. 7b) . Moreover, when these cells were induced to generate EBs, they showed delayed downregulation of pluripotency markers similar to that found with Whsc1 −/− EBs (Fig. 7c ). In conclusion, our data show that the depletion or knockout in ESCs of the mesendoderm regulators Gata6, T, Gata4 and Foxa2 downstream of Whsc1 delays pluripotency exit.
Depletion of mesendoderm transcription factors in ESCs causes
a delay in pluripotency exit. The finding that Whsc1 is associated with the activation of Gata4, T, Gata6 and Foxa2 during ESC differentiation raised the possibility that the encoded mesendoderm instructive transcription factors are downstream mediators of Whsc1 in pluripotency exit and germ layer specification. To test this hypothesis, we transfected Rex1GFPd2 ESCs with small interfering RNAs (siRNAs) against Gata4, T, Foxa2 and Gata6, respectively, resulting in significant downregulation of the genes (
Discussion
Here, we describe that the CRF Whsc1 has a role in both pluripotency exit and germ layer specification of ESCs. Depletion of Whsc1 entraps the cells in a pluripotent state and inhibits their specification towards mesoderm and endoderm lineages, without impairing neuroectoderm formation. Mechanistically, Whsc1 binds to and activates enhancers of mesendoderm lineage-instructive transcription factors during lineage specification, independent of its methyltransferase activity mediated by the SET domain. Moreover, depletion of downstream mesendodermal regulators also delayed pluripotency exit, explaining-at least in part-the effects observed after Whsc1 ablation. 
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Fold enrichement (~180 and ~100 kDa isoforms) and Brd4 co-immunoprecipitated from total protein extracts of day 6 EBs. Inputs correspond to 10% of the total extract. IgG, immunoglobulin G; IP, immunoprecipitation. e, Western blots (WB) of endogenous Whsc1 (~180 and ~100 kDa isoforms) and Gata6 co-immunoprecipitated from total protein extracts of day 6 EBs. Inputs correspond to 10% of the total extract. In d and e, n = 2 independent experiments were performed with similar results, and scanned images of unprocessed blots are shown in Supplementary Fig. 8 . f. ChIP-qPCR quantification of Whsc1 occupancy on Whsc1-bound putative enhancers of T, Gata6, Gata4 and Foxa2 in day 6 Gata6 +/+ and Gata6 −/− EBs. In a-c and f, data represent means ± s.d. from n = 3 independent experiments, and P values were calculated by two-tailed unpaired t-test.
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Several factors previously described to be required for pluripotency exit have been shown to dismantle directly the pluripotencyassociated regulatory network. Hence, folliculin, together with its interaction partners Fnip1 and Fnip2, sequesters the pluripotencyassociated transcription factor Tfe3 in the cytoplasm 13 ; the transcription factors Tcf3, Foxd3 and Zfp706 repress pluripotency gene expression [8] [9] [10] [11] ; and the RNA-binding proteins Mettl3 and Pum1 destabilize pluripotency gene transcripts 11, 12, 32 . In contrast, we have found that Whsc1 does not act primarily on the pluripotency network, but controls the upregulation of mesendodermal regulators, including Gata4, T, Gata6 and Foxa2, which on their own also control pluripotency exit. Our observations suggest that the regulatory networks controlling pluripotency and germ layer specification are intimately linked. Indeed, several studies have shown that, during murine gastrulation in the primitive streak, the pluripotency factors Nanog, Oct4 and Sox2 are co-expressed with the mesendoderm lineage factors T 39 , Gata6 (ref. 40 ) and Foxa2 (ref. 41 ). Moreover, it has been shown that pluripotency transcription factors are crucial for the upregulation of germ layer genes on differentiation, as differentiation fails when pluripotency transcription factors are acutely ablated 7, [42] [43] [44] . In addition, one study also suggested that, during in vitro differentiation of ESCs, GATA6 represses pluripotency factor expression 45 . Our findings support the notion that Whsc1 is recruited to chromatin by lineage regulators. Thus, co-immunoprecipitation experiments showed that Whsc1 interacts with Gata6 and that it loses its ability to bind to most of the mesendodermal enhancers in Gata6-deficient EBs. It is possible that other sites bound by Whsc1 , Gata6 knockout, Foxa2 knockout and control ESCs (wild type) monitored by RT-qPCR after transfer into N2B27 medium containing activin A and FBS. b, Western blot analysis of Oct4 and Nanog in the cells described in a. Tubulin was used as a loading control. n = 2 independent experiments were performed with similar results. Scanned images of unprocessed blots are shown in Supplementary Fig. 8 . c, Expression kinetics of pluripotency genes evaluated by RTqPCR during EB formation using Whsc1 Articles NaTurE CEll BiOlOgy additional regulators are operative, such as has been described for Nkx2.5 in cardiac cells 31 . Our study also showed an interaction between Whsc1 and the transcriptional co-activator Brd4 in EBs, supporting earlier studies 36 . Moreover, EBs lacking Whsc1 showed a reduced binding of Brd4 specifically at mesendodermal enhancers, suggesting that Whsc1 facilitates the recruitment of Brd4 to these enhancers, leading to their activation. The finding that the BRD4 inhibition by the BET (bromodomain and extra-terminal motif) inhibitor JQ1 impairs the upregulation of mesendoderm regulators while dramatically enhancing the expression of ectodermal regulators supports previous observations in ESCs 38 . Together, our data suggest that Whsc1 enables Brd4 to act as a co-activator of mesendodermal enhancers.
In certain forms of cancer, including multiple myeloma and acute lymphoblastic leukaemia, WHSC1 has been found to be either overexpressed or hyper-activated, resulting in increased methylation of H3K36 on promoters of oncogenes that drive the disease 29, 30, 46 . This is mediated by the methyltransferase activity of the SET domain. In contrast, a short isoform of NSD3 (another member of the Nsd family), lacking the SET domain, can act together with Brd4 on enhancers of genes that drive acute myeloid leukaemia 47 . Interestingly, the PWWP domain responsible for this interaction is highly conserved between members of the Nsd family, and in Whsc1 it is located within the N terminus that interacts with Brd4 (ref.
48
).
Patients with Wolf-Hirschhorn syndrome with WHSC1 deletions often exhibit symptoms characteristic of midline defects, including craniofacial malformations and heart defects 49 . These features have been attributed to the SET domain of the protein, since mice lacking this domain of Whsc1 largely reflect this phenotype, exhibiting aberrant craniofacial, cardiac and cartilage structures 31, 50 . It will now be interesting to elucidate whether the function of Whsc1 described here is also involved in gene regulation during embryo development, cardiogenesis and cancer.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41556-019-0342-1. ), β-mercaptoethanol (50 μM), N2 and B27 supplements, the small-molecule inhibitors PD0325901 (1 μM; Selleck Chemicals) and CHIR99021 (3 μM; Selleck Chemicals), and ESGRO LIF (1,000 U ml ), streptomycin (100 μg ml −1 ) and 50 μM β-mercaptoethanol. Mouse EpiSCs (X GFP EpiSCs) 51 were cultured on plastic dishes precoated with fibronectin (EMD Millipore) in DMED/F12 medium, supplemented with MEM Non-Essential Amino Acids solution (1×), sodium pyruvate (1 mM), l-glutamine (2 mM), penicillin (100 U ml ; PeproTech) and basic fibroblast growth factor (12 ng ml −1 ; PeproTech). All culture reagents were from Life Technologies unless noted otherwise.
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RNA interference assay. The pLKO-TRC-based shRNA constructs against Whsc1, Cbx4, L3mbtl3 and shScr were purchased from Sigma-Aldrich (Supplementary  Table 3 ). Lentiviral particles were produced by co-transfecting the constructs with pCMVΔ8.9 and pVSVG vectors in 293T cells. After 48 h, the supernatant was collected and filtered through a 0.22-μm filter, concentrated by ultracentrifugation with 22,000 r.c.f. at 22 °C for 2 h. Precipitated lentiviral particles were suspended in phosphate-buffered saline (PBS) on a shaker at 4 °C for 1 h and stocked at −80 °C. For lentivirus infection, mouse ESCs were disassociated using Accutase (Life Technologies) and washed twice with PBS, then 0.5 × 10 6 cells were suspended with 100 μl medium without inhibitors or LIF, together with concentrated virus and 4 μg ml −1 polybrene (Sigma-Aldrich) and centrifuged at 300g and 37 °C for 90 min. Infected cells were then transferred to gelatin precoated dishes filled with complete medium including inhibitors and LIF. Three days later, infected cells were selected using puromycin (2 μg ml Table 3 ) were electroporated into ESCs using Nucleofector according to the manufacturer's instructions.
Genome editing with CRISPR-Cas9. The two guide RNAs (gRNAs) targeting the Whsc1 locus were designed using the CRISPR design tool from MIT (http://crispr. mit.edu) (Supplementary Table 3 ). After annealing, the two gRNAs were cloned into the DECKO (Double Excision CRISPR Knockout) version of SpCas9(BB)-2A-GFP (PX458) (original backbone from Addgene number 48138) 52 . The DECKO system facilitates genomic deletion by delivering simultaneously two gRNAs plus Cas9 into E14 cells 53 . Then, 24 h after transfection, single cells were sorted by fluorescence-activated cell sorting. Mutant clones were screened through PCR and sequencing to identify homozygously targeted clones.
To generate the Gata6 and Foxa2 knockout E14 ESCs, gRNAs were cloned into the p330 plasmid (https://www.addgene.org/42230/). Together with the gRNA, cells were tagged using a constitutive GFP. Both gRNAs resulted in large deletions and subsequent frame shifts (details can be found in Johanna Goldmann, Denes Hnisz, Amanda Araujo Gomes Ferreira, Stefan Semrau, Richard Young and Rudolf Jaenisch, manuscript in preparation for publication).
Alkaline phosphatase assay. Alkaline phosphatase assays were performed using the Alkaline Phosphatase Staining Kit II (Stemgent) following the instructions provided by the manufacturer.
Assay for pluripotency exit. ESCs were disassociated with Accutase for 2 min at room temperature and washed twice with PBS. Then, 2 × 10 5 cells were seeded in 6-well plates precoated with 0.1% (w/v) EmbryoMax gelatin in culture medium containing N2B27 supplements plus activin A (25 ng ml −1 ; PeproTech) and 10% FBS without the two inhibitors or LIF. GFP expression levels were monitored by flow cytometry on an LSRFortessa analyser (BD Biosciences), and the analysis was performed using Diva version 6.1.2 (BD Biosciences) and FlowJo software version 10.0.6 (TreeStar). In some experiments, Rex1GFPd2 cells that retained GFP expression were selected by adding 10 μg ml −1 blasticidin (Sigma-Aldrich) to the medium.
EB formation, and cardiac progenitor, definitive endoderm and neural progenitor differentiation. ESCs or EpiSCs were induced to form EBs with 'EB differentiation medium' (KnockOut DMEM medium supplemented with 10% FBS, MEM Non-Essential Amino Acids solution (1×), sodium pyruvate (1 mM), l-glutamine (2 mM), penicillin (100 U ml −1 ), streptomycin (100 μg ml −1 ) and 50 μM β-mercaptoethanol and plated as hanging drops (400 cells in 20 μl) on the lid of a 100-mm Petri dish. The cultures were harvested 3 d later and transferred into bacterial dishes for further culture in suspension. The cardiac progenitor differentiation assay was performed as described 17 with slight modifications.
Briefly, ESCs were seeded in hanging-drop EB cultures with DMEM medium containing 10% serum to induce EB formation. Three days later, at least 100 EBs were transferred individually into separate wells of a gelatin precoated 96-well plate supplemented with 100 μl EB differentiation medium and cultured for another 3 d before counting the beating EBs under low-power magnification. The definitive endoderm and neural differentiation protocols were performed as described previously 18, 27 .
Animal experiments and teratoma formation. Teratoma formation assays were performed as described previously 54 . Briefly, knockdown and control ESCs grown under 2i plus LIF conditions (0.5 × 10 6 ) were injected subcutaneously into severe combined immunodeficient mice. Four weeks later, mice with tumours were euthanized, and tumours were either snap-frozen in liquid nitrogen for further gene expression analysis or fixed in formalin, embedded in paraffin, sectioned and stained with haematoxylin and eosin for histological analysis. All experimental procedures were approved by the local ethical committee ( Imaging acquisition and analysis. Fluorescence images were acquired using Leica DMI6000 B fluorescent microscopy. Images of teratoma haematoxylin and eosin staining and EB morphology images were acquired using Leica DM6000 B light microscopy. The Leica application software LAS AF was used to visualize the images. Image J (version 1.15) was used for further analysis 55 .
ChIP assay. ChIP assays in ESCs and EBs were performed using a True MicroChIP Kit (Diagenode) according to the manufacturer's instructions. EBs were crosslinked with 4% formaldehyde for 20 min for H3K27Ac and H3K4me2, or doublecross-linked with DSG (disuccinimidyl glutarate) 2 mM for 30 min, then with 4% formaldehyde for 20 min, for Brd4 and Whsc1. Genomic DNA was purified using MicroChIP DiaPure columns. The antibodies and primers used are listed in Supplementary Table 3 .
Western blot and co-immunoprecipitation analysis. Proteins were extracted using NET-2 buffer (50 mM Tris (pH 7.4), 200 mM NaCl, 0.1% triton and proteases inhibitors) and loaded on sodium dodecyl sulfate polyacrylamide gel electrophoresis gel. For the endogenous co-immunoprecipitation experiments, lysates were prepared using NET-2 buffer, and centrifuged to eliminate insoluble material. The extract was precleared by incubation with magnetic beads for 2 h on a rotating wheel at 4 °C. To crosslink the antibodies to Dynabeads A or G (Life Technologies) magnetic beads, 50 μl of beads were incubated with 3 µg of antibody or immunoglobulin G for 2 h at room temperature on a wheel. The mix was then washed once with PBS and twice with triethanolamine (pH 8.2; 0.2 M) and then incubated for 20 min at room temperature with dimethyl pimelimidate (20 mM). To stop the reaction, two 5 min washes with Tris-Cl (pH 8; 50 mM) were performed, followed by three washes with PBS. Then, beads were incubated with citric acid (0.1 M; pH 3) for 2 min. Finally, the mix was washed twice with lysis buffer before incubating it with the precleared protein extracts overnight at 4 °C on a wheel. Afterwards 1/20th of the mixture was kept as the unbound fraction and the rest was washed six times with lysis buffer. To elute, the last wash was removed and the beads resuspended in 1× Laemmli buffer without β-mercaptoethanol and heated for 20 min at 60 °C. Magnetic beads were then separated and supernatant was taken, complemented with 5% β-mercaptoethanol and boiled before loading on a sodium dodecyl sulfate polyacrylamide gel to analyse the bound proteins by western blotting.
Gene expression analysis. Total RNA was isolated using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. Double-stranded complementary DNA (cDNA) was synthesized using the High Capacity RNA-tocDNA Kit (Applied Biosystems). Real-time PCR was performed on a ViiA 7 system using Power SYBR Green PCR Master Mix (Applied Biosystems). The relative gene expression levels were calculated using the 2 −ΔΔCt method. Primers can be found in Supplementary Table 3 . RNA-Seq libraries were prepared using the Illumina TruSeq Stranded mRNA Library Prep Kit followed by single-end sequencing (50 bp) on an Illumina HiSeq 2500. Single-end reads were mapped using STAR2.5 (ref. 56 ). Gene expression was quantified using STAR (-quantMode GeneCounts) and the Mouse GENCODE (release M17). Sample scaling and statistical analysis were performed using R version 3.3.2. Reads per kilobase of transcript per million mapped reads (RPKM) values were used as an absolute measure of gene expression, and genes with RPKM values of <1.0 in at least two samples were removed. Genes with significant differential expression were identified with a t-test (P < 0.05) and an absolute fold change of >2.
Chromosome conformation capture followed by high-throughput sequencing data generation and analysis. Two independent replicates of Whsc1 +/+ and Whsc1 −/− embryonic stem cells and day 6 EBs were prepared following the protocol described 57 . Briefly, two million cells were cross-linked using 1% formaldehyde and quenched using 0.125 M glycine. The cell pellet was lysed in prepared ice-cold HiC lysis buffer (10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 0.2% IGEPAL CA-630 and 1× Roche complete protease inhibitors). The chromatin was then digested using MboI (NEB R147M) at 37 °C in four rounds as follows: 100 U for 2 h, 100 U for 2 h, 100 U overnight and 100 U for 2 h. An aliquot was taken from the tube and analysed by gel electrophoresis to inspect digestion efficiency. If digestion was successful, the restriction enzyme was inactivated by incubating at 65 °C for 20 min. Next, the chromatin was ligated with 10,000 U T4 ligase (NEB M0202M) with 10× ligase buffer to a final volume of 1.5 ml, and incubated overnight at 24 °C. Ligation efficiency was inspected by gel electrophoresis on an aliquot of the sample. The chromatin was then reverse cross-linked for 1 h at 55 °C with 50 μl proteinase K (Sigma-Aldrich; 20 mg ml
) and 10 μl RNase A (Sigma-Aldrich; R4642) for 4 h at 65 °C. The 3C DNA was then extracted with ethanol precipitation and resuspended in Tris buffer (10 mM Tris-HCl; pH 8). 3C aliquots were stored at −20 °C for later use. 4C primers were designed flowing a nested approach involving a set of two primers for each locus, thereby improving specificity. The primer for the second PCR reaction should ideally be located 5-15 bp from the interrogated restriction site. The primer used in the first PCR reaction is designed upstream of the second primer with no overlap. For multiplexing, we designed primers independently, aiming for a melting temperature (T m ) of 60-65 °C. A list of the primers used in this study is provided in Supplementary Table 3 . Some 3 µg of DNA in 300 μl Tris buffer (10 mM Tris-HCl; pH 8) of 3C template was sonicated at 4 °C for seven cycles of 30 s on, 60 s off on a Bioruptor (Diagenode). The sonicated material was inspected by gel electrophoresis of 5 μl aliquots. The sonicated DNA was subjected to an endrepair reaction-10 μl 10× end-repair buffer and 5 μl end-repair mix (NEB E6050L) were added to the sonicated DNA and incubated at 20 °C for 30 min. The DNA was cleaned with 1.1× AMPure XP beads (Beckman Coulter) and eluted in 42 μl Tris buffer. A-tailing was performed by adding 5 μl NEBNext dA-Tailing Reaction Buffer and 3 μl Klenow Fragment (NEB M0212M). Following A-tailing, the 5′ ends of the DNA were dephosphorylated by adding 2 μl calf intestinal alkaline phosphatase (NEB M0290S), and incubated for 30 min at 37 °C and 60 min at 50 °C. The DNA was cleaned with 1.1× AMPure XP beads and eluted in 35 μl elution buffer (10mM Tris-Cl). The DNA template was ligated with 3 μl NEBNext Adaptor, 2 μl Quick T4 DNA Ligase and 10 µl 5× Quick Ligation Reaction Buffer for 15 min at 20 °C. Then, 3 μl of USER Enzyme was added and incubated at 37 °C for 15 min. To release the non-ligated strand of the adaptor, the DNA was denatured at 95 °C for 2 min and cleaned with 1× AMPure XP beads. Two nested PCR reactions were used for 4C library construction. The PCR reactions were performed in a 50 μl volume with the following reagents: 10 μl Herculase II 5× buffer, 0.25 mM dNTPs, 3.75 μl 10 mM bait primer, 3.75 μl 10 mM universal primer (Nextera; NEB), 1 µl Herculase II polymerase and 10 µl DNA template. The PCR programme was as follows: 2 min at 95 °C, 15 cycles of 30 s at 95 °C, 30 s at 60 °C and 60 s at 72 °C, and final extension of 5 min at 72 °C. Ten percent of the first PCR product was used as a template in the second PCR reaction. Conditions for the second PCR reaction were identical to the first; the only difference was the use of the nested-bait primer. PCR products for each library were purified with a 1.1× AMPure XP bead. The libraries were then pooled and diluted to a concentration of 4 nM, multiplexed with other libraries and sequenced on an Illumina HiSeq 2500.
For data analysis, we first preprocessed the reads, splitting them according to the restriction enzyme motif, and obtaining read fragments. Then, we aligned them against the mm10 genome using BWA (0.7.17; r1188) 58 with all default arguments. We removed all duplicate and supplementary alignments (sam flag ≥ 2,048), as well as those with a mapping quality below 20. For each bait, we summarized the information per restriction fragment, computing the tally of read fragments and obtaining a raw contact profile. We defined the region of interest as all restriction fragments within a 2-250-kb distance to the bait. To smooth the profiles, we increased the size of each restriction fragment, aggregating the adjacent restriction fragments sequentially until a threshold in contacts was reached (5% of the total number of raw contacts in the region of interest). We used a linear mixed model 59, 60 to integrate replicates and compare conditions. In detail, we modelled the logsmoothed contacts per restriction fragment, assuming a linear decay with the log distance to the bait that was different at each side of it. We included both random intercepts and slopes on the restriction fragment level (the slope defined at the condition to compare). From this model, we obtained point and 95% confidence interval estimates for: (1) the average profile per condition; and (2) the fold change between them (corresponding to the random slopes of the restriction fragments).
Statistics and reproducibility. Statistical analysis was performed using Prism 6 software. The P values were calculated either by two-tailed unpaired Student's t-test or two-tailed Mann-Whitney U-test (Supplementary Table 4 
Data availability
The RNA-Seq and UMI-4C data generated have been deposited in the Gene Expression Omnibus under accession number GSE126618. The accession numbers of the published datasets used are as follows: HiC in ESCs: GSE96611 (ref. 61 Last updated by author(s): April 16, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code Data collection FACS data were collected using FACS Diva V6.1.2 (BD Bioscience). qPCR data were collected using ViiA7 software. Leica application software LAS AF were used to visualize and collect images Data analysis Statistical analysis was performed using PRISM 6 software. The p values were calculated using either two-tailed unpaired Student's t test or two-tailed Mann-Whitney test (Supplementary Table 4) . FACS data were analyzed using Diva v6.1.2 (BD Biosciences) and FlowJo software v10.0.6 (TreeStar). Image J (Version1.15) was used for imaging analysis For RNA-seq Single-end reads were mapped using STAR2.5. Gene expression was quantified using STAR (--quantMode GeneCounts) and the Gencode mouse Release M17. Sample scaling and statistical analysis were performed using R3.3.2. RPKM values were used as an absolute measure of gene expression, and genes with RPKM values less than 1.0 in at least two samples were removed. Genes with significant differential expression were identified with a t-test (P Value<0.05) and absolute Fold Change >2. For UMI-4C We first pre-processed the reads splitting them according to the restriction enzyme (RE) motif and obtaining read fragments. Then we aligned them against the mm10 genome using bwa (0.7.17-r1188) [1] with all default arguments. We removed all duplicate and supplementary alignments (sam flag >= 2048) as well as those with a mapping quality below 20. For each bait, we summarize the information per restriction fragment, computing the tally of read fragments and obtaining a raw contact profile. We defined the region of interest as all restriction fragments within 2 Kbp and 250 Kbp distance to the bait. In order to smooth the profiles, we increased the size of each restriction fragment aggregating the adjacent restriction fragments sequentially until a threshold in contacts was reached (5 % of the total number of raw contacts in the region of interest). We used a linear mixed model [2, 3] to integrate replicates and compare conditions. In detail: We modeled the log smoothed contacts per restriction fragment assuming a linear decay with the log distance to the bait, different at each side of it. We included both random intercepts and slopes on the restriction fragment level (the slope defined at the condition to compare). From this model we obtained point and 95% CI estimates for 1) The average profile per condition 2) The fold change between them (corresponding to the random slopes of the restriction fragments). The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
Rex1GFPd2 cells or EomesGFP reporter cells were dissociated with accutase then washed twice with PBS 1X, and stained with DAPI before FACS analysis.
Instrument
GFP expression level was monitored by flow cytometry on a LSR Fortessa analyser (BD Bioscience).
Software
The analysis was performed using Diva v6.1.2 (BD Biosciences) and FlowJo software v10.0.6 (TreeStar).
Cell population abundance Purity of cell analyzed was determined by independent immunofluorescence imaging. E14TG2a cells (GFP-) were routinely used as negative control to gate GFP positive population.
Gating strategy
We used FSC and SSC gates to include at least 90% of events and to exclude very small events. Then we use SSC-A and -H to discriminate for single cells (doublets were excluded for further analysis). Third, DAPI were used to discriminate live cells from dead ones. GFP and RFP gating was performed using negative controls from the respective cell lines tested. Example of gating strategy was shown in Supplementary Fig. 7 Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
